VirnetX Inc. v. The Mangrove Partners (Fed. Cir. 2018)

BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 

BIO 2018 to Feature Rob Reiner as Keynote Speaker

Aactor, director and advocate Rob Reiner will deliver a keynote address at the 2018 BIO International Convention, the world’s premier life sciences event being held in Boston, June 4-7. Reiner’s family story of drug addiction reinforces the urgent need for biotechnology innovation in pain management

Food Evolution Writer/Producer Trace Sheehan to Keynote Food & Ag Program at BIO Int’l Convention

Washington, D.C. (May 16, 2018) – Trace Sheehan, writer and producer of the highly-acclaimed documentary film Food Evolution, will be a keynote speaker at BIO’s International Convention in Boston, the Biotechnology Innovation Organization (BIO) announced today.

BIO Statement on Trump Administration’s Plan to Lower Drug Costs

“We have concerns that some of the ideas proposed today could, if adopted, hurt patient access to the medicines they need …”

BIO’s Statement on PTO’s Proposed Changes to the Claim Construction Standard for PTAB Proceedings

Washington, D.C. (May 9, 2018) – Biotechnology Innovation Organization President for Advocacy, Law & Public Policy Tom DiLenge today issued the following statement in response to the U.S....

BIO Thanks President Trump for Rejecting RIN Cap, Supporting E15

BIO thanked President Trump and Senators Charles Grassley (R-IA) and Joni Ernst (R-IA) for rejecting a price cap on Renewable Identification Numbers (RINs) and working to provide regulatory relief to enable year-round sales of E15.

BIO Launches New Report Profiling 100 Renewable Chemical Technology Companies

BIO's new “Renewable Chemical Platforms Building the Biobased Economy” report documents the rapid expansion of renewable chemical platforms and applications around the world, profiling 100 companies from 16 countries that are commercializing renewable chemical applications.

Wisconsin Governor Walker Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines

Washington, D.C. (April 10, 2018) – The Biotechnology Innovation Organization (BIO) and BioForward Wisconsin commend...

BIO Applauds Introduction of the Opioid Addiction Action Plan Act

Washington, DC (April 27, 2018) – BIO President and CEO Jim Greenwood issued the following statement regarding the Opioid Addiction Action Plan Act, introduced yesterday in the Senate by Senators Heller (R-NV), Isakson (R-GA), and Menendez (D-NJ). A companion bill in the House, sponsored by Representatives Yvette Clarke (D-NY) and Adam Kinzinger (R-IL), was advanced by the House Energy and Commerce Health Subcommittee earlier this week.

BIO Announces Gene Editing and Synthetic Biology Programming for 2018 World Congress

WASHINGTON, D.C. (April 26, 2018) – The Biotechnology Innovation Organization (BIO) today announced programming information for gene editing and synthetic biology at the 2018 World Congress on Industrial Biotechnology. Programming around these topics will kick off on Tuesday, July 17, with a plenary panel of experts to discuss how gene editing tools like CRISPR are revolutionizing the production of everyday products. Programming will continue with breakout sessions throughout the week, featuring executives from biotechnology companies, consumer goods producers and the government to explore the various applications for gene editing and synthetic biology in the field of industrial biotechnology.